Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours; systematic review and economic evaluation

J. Wilson; M. Connock; F. Song; G. L. Yao; A. Fry-Smith; J. Raftery; D. Peake

doi:10.3310/hta9250

Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours; systematic review and economic evaluation

J. Wilson, M. Connock, F. Song, G. L. Yao, A. Fry-Smith, J. Raftery, D. Peake

Research output: Contribution to journal › Article

57 Citations (Scopus)

Original language	English
Pages (from-to)	1-142
Number of pages	142
Journal	Health Technology Assessment
Volume	9
Issue number	25
DOIs	https://doi.org/10.3310/hta9250
Publication status	Published - 2005

Access to Document

10.3310/hta9250

Cite this

@article{4d453f2e197742f2af460ea3ab59329b,

title = "Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours; systematic review and economic evaluation",

author = "J. Wilson and M. Connock and F. Song and Yao, {G. L.} and A. Fry-Smith and J. Raftery and D. Peake",

year = "2005",

doi = "10.3310/hta9250",

language = "English",

volume = "9",

pages = "1--142",

journal = "Health Technology Assessment",

issn = "2046-4924",

publisher = "National Co-ordinating Centre for HTA",

number = "25",

}

TY - JOUR

T1 - Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours; systematic review and economic evaluation

AU - Wilson, J.

AU - Connock, M.

AU - Song, F.

AU - Yao, G. L.

AU - Fry-Smith, A.

AU - Raftery, J.

AU - Peake, D.

PY - 2005

Y1 - 2005

U2 - 10.3310/hta9250

DO - 10.3310/hta9250

M3 - Article

SN - 2046-4924

VL - 9

SP - 1

EP - 142

JO - Health Technology Assessment

JF - Health Technology Assessment

IS - 25

ER -